Canadian Medical Center CoSAU:4021 +3.26%78 EBITDA Margin % is 14.93% as of Mar. 2026, which is 36% below its 10-year median of 23.51. GuruFocus rates SAU:4021 with a GF Score™ of 78/100 and a GF Value™ of ﷼10.71 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Canadian Medical Center Co ranks better than 50.6% on this metric.
Canadian Medical Center Co (SAU:4021) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Canadian Medical Center Co EBITDA Margin % Related Terms
Canadian Medical Center Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4021 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Canadian Medical Center Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canadian Medical Center Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Canadian Medical Center Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Canadian Medical Center Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Canadian Medical Center Co (SAU:4021) has a EBITDA Margin % of 14.93% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Canadian Medical Center Co and its competitors. This is 36% below median its historical median of 23.51. Over the past decade, Canadian Medical Center Co's EBITDA Margin % has ranged from 10.33 to 31.30. According to the industry distribution chart, Canadian Medical Center Co ranks #329 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 49.4%.
Is Canadian Medical Center Co's EBITDA Margin % too high?
Canadian Medical Center Co's current EBITDA Margin % of 14.93% is 36% below median its 10-year median of 23.51. Over the past 10 years, this metric has ranged from a low of 10.33 to a high of 31.30. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Canadian Medical Center Co's value of 14.93% is 45.9% above this industry median. Based on the distribution chart, Canadian Medical Center Co ranks #329 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Canadian Medical Center Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Canadian Medical Center Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Canadian Medical Center Co ranks #329 out of 666 companies for EBITDA Margin %. This puts Canadian Medical Center Co in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Canadian Medical Center Co's value of 14.93% is 45.9% above this benchmark. Historically, Canadian Medical Center Co's own EBITDA Margin % has ranged from 10.33 to 31.30 over the past decade. While the company's 10-year median is 23.51 vs. the industry median of 10.24, Canadian Medical Center Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Canadian Medical Center Co's current EBITDA Margin % of 14.93% is 45.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Canadian Medical Center Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Canadian Medical Center Co's current EBITDA Margin % is 14.93%, which is 36% below median its own 10-year median of 23.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canadian Medical Center Co stock overvalued right now?
Based on GuruFocus' analysis, Canadian Medical Center Co (SAU:4021) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼10.71, compared to a current price of ﷼6.27 — trading 41.5% below its estimated fair value. The current EBITDA Margin % is 14.93%, which is 36% below median its 10-year median of 23.51 and 45.9% above the Healthcare Providers & Services industry median of 10.24. Canadian Medical Center Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Canadian Medical Center Co (SAU:4021), the current EBITDA Margin % is 14.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Canadian Medical Center Co (SAU:4021) Overvalued in 2026?
Based on GuruFocus' analysis, Canadian Medical Center Co stock appears to be undervalued.
The current stock price of ﷼6.27 is trading 41.5% below its estimated GF Value™ of ﷼10.71.
GuruFocus considers Canadian Medical Center Co to be Significantly Undervalued.
Key valuation signals for SAU:4021:
EBITDA Margin %: 14.93% (36% below median its 10-year median of 23.51)
GF Value™: ﷼10.71 vs. price of ﷼6.27 (41.5% below fair value)
Industry Position: 45.9% above the Healthcare Providers & Services median (#329 of 666)
No single metric tells the full story. See the SAU:4021 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Canadian Medical Center Co is a provider of emergency medical care solutions and integrated healthcare services management. The company offers a wide range of medical services, including operating on-site clinics, medical coverage for events and projects, and ambulance transportation services supported by a fleet of modern ambulances and trained and licensed medical teams. Its services include Medical Centers, Medical Support at Onshore and Offshore Sites, Medical Support at Construction Sites, Medical Support at Industrial Sites, Medical Coverage for Events, Ambulance Services, Home Health Care, Medical Training, Medical Examinations, and Ambulance Transports.
78GF Score
Get the complete analysis for SAU:4021
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4021 has been successfully added to your 
